Kinnevik stock
KINV-B.STSTOKinnevik AB, Financial ServicesISIN SE0022060521
32Score 32 out of 100, Weak
Price and trend
81 / 100
Price history
−16% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 22% above it.
Since October 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 64).
The price is 19% below its 52-week high. Largest decline in 20 years: 88% (August 2021 to March 2026).
Chart figures for advanced users
- SMA 50$6.56
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$5.85
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)64
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$4.77
- The lowest closing price of the last twelve months.
- Resistance$8.79
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Kinnevik AB belongs to the Financial (Conglomerates) industry (Sweden) and, with a market value of $1.97B, is number 19 of 25 companies in its industry on MEQIRI.
- MEQIRI Score 32 out of 100 (Weak): rank 954 of 975 in Financial Services, median 68.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
None of our strength checks applies.
Weaknesses
- Revenue shrinkingRevenue down 81.1% a year since 2020.Growth 5
- Loss-makingLoss of $335.51M over the last 12 months.Fundamentals 15
- Turned to a lossEarnings per share from $14.57 in 2020 to −$1.21.Growth 5
Its standout strength is technical analysis, while profitability and growth hold the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
One-off effect in revenue
In the quarter to 30 Jun 2026, revenue of $174.57M was about 15 times the usual level. P/E, margin, growth and score for the last twelve months depend on it.
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansValuation
Valuation signal
not measuredNo fair value can be calculated for this stock, so the signal follows the valuation grade.
Valuation metrics
No fair value can be calculated for this stock from the available figures.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
Revenue swung sharply, with 6 of 20 years negative.
Margins
- Operating margin
- Net margin
In fiscal 2025: operating −45540%, net −33460%. Banks and insurers have no gross margin, and their net margin is not comparable with other industries. The score leaves both out. Last 12 months: net 100%.
Debt & balance sheet
latest quarterFor banks and insurers, deposits and liabilities are the business. Debt to equity and the current ratio say little here, and the score does not rate them.
Earnings
- Next earnings
- 4 Feb 2027in 83 days
- Last reported
- 15 Oct 2026EPS reported $0.08
Analyst estimates
- Earnings per share
- $0.00−99.8%
- Revenue
- $661.89M+821.9%
- Earnings per share
- $0.05−72.5%
- Revenue
- $694.78M+821.9%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: −9.2%Several portfolio companies were valued lower because of updated growth expectations, but the company states there is no material downgrade of the outlook, for example at Pleo.
“You said earlier that you when explaining the lower valuations of Muse and Oviva, you said you had updated some of the forward growth estimates for some of your holdings, I think.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 15 Oct 2026 (fiscal Q3 2026), read by AI.
What happened at Kinnevik
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
975 rated companies in Financial Services
- This company
- 32
- Sector median
- 68
Categories against the sector medianMedian of 975 companies
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Financial (Conglomerates)
The next larger and next smaller companies by market value
- Compagnie de l'OdetODET.PA $4.76B43
- BB BiotechBION.SW $3.63B69
- MandatumMANTA.HE $3.25B50
- Financière MonceyFMONC.PA $2.16B41
- Storskogen GroupSTOR-B.ST $1.96B61
- RatosRATO-B.ST $1.39B51
- Compagnie du Bois SauvageCOMB.BR $509.82M66
- Evernorth HoldingsXRPN $315.2M23
ETFs that hold Kinnevik
Held by 9 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares Listed Private Equity UCITS ETFIQQL | 0.67% | 0.75% | €685.36M |
| Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF DistX026 | 0.20% | 0.23% | €321.86M |
| Xtrackers MSCI Europe Small Cap UCITS ETF 1CXXSC | 0.10% | 0.30% | €3.45B |
Show 5 more
| State Street SPDR MSCI Europe Small Cap Value Weighted UCITS ETF EUR AccZPRX | 0.10% | 0.30% | €813.64M |
| iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG | 0.07% | 0.10% | €395.74M |
| State Street SPDR MSCI World Small Cap UCITS ETF (Acc)ZPRS | 0.03% | 0.45% | €1.54B |
| Vanguard FTSE Global All-Cap UCITS ETF Accum USDVGLA | 0.00% | 0.07% | €3.9B |
| Vanguard ESG Global All Cap UCITS ETF (USD) AccumulatingV3AA | 0.00% | 0.24% | €1.69B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = SEK 9.9729)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 30 Apr 2023)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.